氟比洛芬酯

  • 基本信息
  • 制备方法及用途
  • 物化性质
  • 毒理性
  • 结构与计算化学

氟比洛芬酯 基本信息

中文名称:
氟比洛芬酯 
中文别名:
氟比洛芬酯;
2-氟-Α-甲基-(1,1'-联苯)-4-乙酸1-(乙酰氧基)乙基酯 
英文名称:
[1,1'-Biphenyl]-4-aceticacid, 2-fluoro-a-methyl-,1-(acetyloxy)ethyl ester
英文别名:
1-acetyloxyethyl 2-(3-fluoro-4-phenylphenyl)propanoate;
flurbiprofen axetil;
Ropion;
Lipo-flurbiprofen axetil;
LFP 83;
Lipfen;
Liposomal flurbiprofen axetil;
Ropiopn;
FP 83;
1-Acetoxyethyl 2-(2-fluoro-4-biphenylyl)propionate 
CAS No.:
91503-79-6
分 子 式:

C19H19FO4

分 子 量:
330.35
精确分子量:
330.12700
PSA:
52.60000
InChI:
InChI=1/C19H19FO4/c1-12(19(22)24-14(3)23-13(2)21)16-9-10-17(18(20)11-16)15-7-5-4-6-8-15/h4-12,14H,1-3H3
危险品标志:

 

风险术语:

 

安全术语:
分子结构式:
SDS:
查看

氟比洛芬酯 制备方法及用途

制备方法

氟比洛芬溶于二甲基甲酰胺,加入碳酸钾和乙酸卜氯乙基酯,在室温搅拌反应,即得氟比洛芬酯。

合成制备方法

氟比洛芬溶于二甲基甲酰胺,加入碳酸钾和乙酸卜氯乙基酯,在室温搅拌反应,即得氟比洛芬酯。

用途简介

为氟比洛芬的前体药物。用于手术后及各种癌症的镇痛。

用途

为氟比洛芬的前体药物。用于手术后及各种癌症的镇痛。

氟比洛芬酯 物化性质

密度:
1.169g/cm3
沸点:
424.3ºC at 760 mmHg
闪点:
203ºC
折射率:
1.528
其它信息:

1.性状:无色至微黄色透明油状物,略臭,味苦。

2.溶解度:和甲醇、乙醇、乙腈或丙酮混溶,不溶于水。

氟比洛芬酯 毒理性

CHEMICAL IDENTIFICATION

RTECS NUMBER :
DU8342000
CHEMICAL NAME :
(1,1'-Biphenyl)-4-acetic acid, 2-fluoro-alpha-methyl-, 1-(acetyloxy)ethyl ester
CAS REGISTRY NUMBER :
91503-79-6
LAST UPDATED :
199806
DATA ITEMS CITED :
14
MOLECULAR FORMULA :
C19-H19-F-O4
MOLECULAR WEIGHT :
330.38

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
66 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - ataxia Lungs, Thorax, or Respiration - respiratory stimulation
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 22,3949,1988
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
66 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - ataxia Lungs, Thorax, or Respiration - respiratory stimulation
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 22,3949,1988
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
88 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - ataxia Lungs, Thorax, or Respiration - respiratory stimulation
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 22,3949,1988
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
69 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - ataxia Lungs, Thorax, or Respiration - respiratory stimulation
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 22,3949,1988
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
183 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - ataxia Lungs, Thorax, or Respiration - respiratory stimulation
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 22,3949,1988
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
194 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - ataxia Lungs, Thorax, or Respiration - respiratory stimulation
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 22,3949,1988
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Primate - monkey
DOSE/DURATION :
188 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - muscle contraction or spasticity Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
JZKEDZ Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. (Jikken Dobutsu Chuo Kenkyusho, 1433 Nogawa, Takatsu-ku, Kawasaki 211, Japan) V.1- 1975- Volume(issue)/page/year: 14,81,1988 ** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Primate - monkey
DOSE/DURATION :
700 mg/kg/4W-I
TOXIC EFFECTS :
Kidney, Ureter, Bladder - urine volume increased Kidney, Ureter, Bladder - other changes in urine composition Kidney, Ureter, Bladder - other changes
REFERENCE :
JZKEDZ Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. (Jikken Dobutsu Chuo Kenkyusho, 1433 Nogawa, Takatsu-ku, Kawasaki 211, Japan) V.1- 1975- Volume(issue)/page/year: 14,87,1988
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Primate - monkey
DOSE/DURATION :
910 mg/kg/26W-I
TOXIC EFFECTS :
Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
JZKEDZ Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. (Jikken Dobutsu Chuo Kenkyusho, 1433 Nogawa, Takatsu-ku, Kawasaki 211, Japan) V.1- 1975- Volume(issue)/page/year: 14,109,1988 ** REPRODUCTIVE DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
1 mg/kg
SEX/DURATION :
female 21 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 20,42,1989
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
415 mg/kg
SEX/DURATION :
male 61 day(s) pre-mating female 15 day(s) pre-mating - 7 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea) Reproductive - Fertility - other measures of fertility Reproductive - Effects on Embryo or Fetus - other effects to embryo
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 16,3671,1988
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
110 mg/kg
SEX/DURATION :
female 7-17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death Reproductive - Effects on Newborn - physical Reproductive - Effects on Newborn - delayed effects
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 16,3689,1988
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
26 mg/kg
SEX/DURATION :
female 17 day(s) after conception - 21 day(s) post-birth
TOXIC EFFECTS :
Reproductive - Maternal Effects - parturition Reproductive - Effects on Embryo or Fetus - fetal death Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4 per # born alive)
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 16,3713,1988
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
1040 mg/kg
SEX/DURATION :
female 6-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - abortion Reproductive - Effects on Embryo or Fetus - fetal death
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 16,3731,1988

氟比洛芬酯 分子结构与计算化学数据

分子结构数据

1、  摩尔折射率:87.06

2、  摩尔体积(cm3/mol):282.3

3、  等张比容(90.2K):708.7

4、  表面张力(dyne/cm):39.7

5、  极化率(10-24cm3):34.51

计算化学数据

1.疏水参数计算参考值(XlogP):无

2.氢键供体数量:0

3.氢键受体数量:5

4.可旋转化学键数量:7

5.互变异构体数量:无

6.拓扑分子极性表面积52.6

7.重原子数量:24

8.表面电荷:0

9.复杂度:433

10.同位素原子数量:0

11.确定原子立构中心数量:0

12.不确定原子立构中心数量:2

13.确定化学键立构中心数量:0

14.不确定化学键立构中心数量:0

15.共价键单元数量:1

推荐供应商更多供应商>>

淄博航宇生物科技发展有限公司

产品介绍:
产品名称:氟比洛芬酯 Cas号:91503-79-6 纯度:99% 包装信息:100kg 价格:洽谈
联系方式:
联系人:张经理 电话:15666366704 手机:15666366704

尚德药缘 (天津)生物制药有限公司

产品介绍:
产品名称:氟比洛芬酯 Cas号:91503-79-6 纯度:99% 包装信息:100mg,500mg,1g 价格:洽谈
联系方式:
联系人:刘经理 电话:022-83718541 手机:13132578992

上海吉至生化科技有限公司

产品介绍:
产品名称:氟比洛芬酯 Cas号:91503-79-6 纯度:98%,非对映异构体混合物 包装信息:200mgea 价格:958.0元
联系方式:
联系人:Shirley张 电话:021-57520831 手机:18116052675

湖北恩星生物科技有限公司

产品介绍:
产品名称:氟比洛芬酯 Cas号:91503-79-6 纯度: 包装信息:100kg,200kg,300kg,400kg,500kg 价格:64.0元 - 100.0元
联系方式:
联系人:邵经理 电话:16621771607 手机:16621771607

钟祥市耀威生物科技有限公司

产品介绍:
产品名称:氟比洛芬酯 91503-79-6 Cas号:91503-79-6 纯度:99% 包装信息:1kg,25kg,1kg 价格:洽谈
联系方式:
联系人:李经理 电话:15337241005 手机:15337241005

上海华理生物医药股份有限公司

产品介绍:
产品名称:氟比洛芬酯 Cas号:91503-79-6 纯度:98% 包装信息:1kg 价格:1.0元
联系方式:
联系人:陈 电话:021-64968998 手机:13636520539

湖北众善奉行医药科技有限公司

产品介绍:
产品名称:氟比洛芬酯 Cas号:91503-79-6 纯度:98 包装信息:100g 价格:洽谈
联系方式:
联系人:张丽 电话:027-61907345 手机:13397111514

彩迩文(上海)生化科技有限公司

产品介绍:
产品名称:氟比洛芬酯 Cas号:91503-79-6 纯度:98%min 包装信息:g1,500g1,kg1,5kg1,25kg1 价格:洽谈
联系方式:
联系人:王东 电话:021-50790412 手机:

武汉灵灵九生物科技有限公司

产品介绍:
产品名称:氟比洛芬酯 Cas号:91503-79-6 纯度:98.5% 包装信息:10g,100g,1kg,咨询客服 价格:洽谈
联系方式:
联系人:刘晓燕 电话:15623309010 手机:15623309010

天津卡普希科技有限公司

产品介绍:
产品名称:氟比洛芬酯 Cas号:91503-79-6 纯度:99.7% 包装信息:洽谈 价格:洽谈
联系方式:
联系人:刘琼 电话:022-66211079 手机:15270500295
QQ: 2241752642
微信二维码
电话: 19906633110